These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 1691604

  • 1. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
    Eggleston PA, Kagey-Sobotka A, Proud D, Adkinson NF, Lichtenstein LM.
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
    [Abstract] [Full Text] [Related]

  • 2. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ, Peachell PT, Lichtenstein LM.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
    [Abstract] [Full Text] [Related]

  • 3. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
    Heavey DJ, Ernst PB, Stevens RL, Befus AD, Bienenstock J, Austen KF.
    J Immunol; 1988 Mar 15; 140(6):1953-7. PubMed ID: 2450136
    [Abstract] [Full Text] [Related]

  • 4. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M, Horowitz EM, Botana LM, MacGlashan DW, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM.
    J Immunol; 1992 Jul 15; 149(2):599-608. PubMed ID: 1378071
    [Abstract] [Full Text] [Related]

  • 5. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells.
    Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM.
    Am Rev Respir Dis; 1984 Jul 15; 130(1):86-91. PubMed ID: 6430138
    [Abstract] [Full Text] [Related]

  • 6. The pharmacologic control of mediator release from human basophils and mast cells.
    Peters SP, Naclerio RM, Schleimer RP, MacGlashan DW, Pipkorn U, Lichtenstein LM.
    Respiration; 1986 Jul 15; 50 Suppl 2():116-22. PubMed ID: 3494282
    [Abstract] [Full Text] [Related]

  • 7. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
    Marone G, Columbo M, Galeone D, Guidi G, Kagey-Sobotka A, Lichtenstein LM.
    Agents Actions; 1986 Apr 15; 18(1-2):100-2. PubMed ID: 2425566
    [Abstract] [Full Text] [Related]

  • 8. Arachidonic acid metabolism in purified human lung mast cells.
    Peters SP, MacGlashan DW, Schulman ES, Schleimer RP, Hayes EC, Rokach J, Adkinson NF, Lichtenstein LM.
    J Immunol; 1984 Apr 15; 132(4):1972-9. PubMed ID: 6199420
    [Abstract] [Full Text] [Related]

  • 9. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
    Stellato C, Cirillo R, de Paulis A, Casolaro V, Patella V, Mastronardi P, Mazzarella B, Marone G.
    Anesthesiology; 1992 Nov 15; 77(5):932-40. PubMed ID: 1280014
    [Abstract] [Full Text] [Related]

  • 10. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
    Levi-Schaffer F, Dayton ET, Austen KF, Hein A, Caulfield JP, Gravallese PM, Liu FT, Stevens RL.
    J Immunol; 1987 Nov 15; 139(10):3431-41. PubMed ID: 2445814
    [Abstract] [Full Text] [Related]

  • 11. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
    Marone G, Cirillo R, Genovese A, Marino O, Quattrin S.
    Life Sci; 1989 Nov 15; 45(19):1745-54. PubMed ID: 2480501
    [Abstract] [Full Text] [Related]

  • 12. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V, Meliota S, Marino O, Patella V, de Paulis A, Guidi G, Marone G.
    J Pharmacol Exp Ther; 1993 Dec 15; 267(3):1375-85. PubMed ID: 7505332
    [Abstract] [Full Text] [Related]

  • 13. Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cells.
    Warner JA, Lichtenstein LM, MacGlashan DW.
    J Pharmacol Exp Ther; 1988 Oct 15; 247(1):218-22. PubMed ID: 3139865
    [Abstract] [Full Text] [Related]

  • 14. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells.
    Marone G, Columbo M, de Paulis A, Cirillo R, Giugliano R, Condorelli M.
    Agents Actions; 1986 Apr 15; 18(1-2):103-6. PubMed ID: 2425567
    [Abstract] [Full Text] [Related]

  • 15. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
    Triggiani M, Giannattasio G, Balestrieri B, Granata F, Gelb MH, de Paulis A, Marone G.
    Clin Exp Allergy; 2004 Feb 15; 34(2):241-9. PubMed ID: 14987304
    [Abstract] [Full Text] [Related]

  • 16. Human neutrophil-derived histamine-releasing activity (HRA-N) causes the release of serotonin but not arachidonic acid metabolites from rat basophilic leukemia cells.
    Igarashi Y, Lundgren JD, Doerfler ME, Shelhamer JH, Kaliner MA, White MV.
    J Allergy Clin Immunol; 1992 Jun 15; 89(6):1085-97. PubMed ID: 1376734
    [Abstract] [Full Text] [Related]

  • 17. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes.
    Levi-Schaffer F, Austen KF, Caulfield JP, Hein A, Gravallese PM, Stevens RL.
    J Immunol; 1987 Jul 15; 139(2):494-500. PubMed ID: 2439587
    [Abstract] [Full Text] [Related]

  • 18. Mediator release from human basophils and mast cells from lung and intestinal mucosa.
    Fox CC, Kagey-Sobotka A, Schleimer RP, Peters SP, MacGlashan DW, Lichtenstein LM.
    Int Arch Allergy Appl Immunol; 1985 Jul 15; 77(1-2):130-6. PubMed ID: 2409011
    [No Abstract] [Full Text] [Related]

  • 19. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
    Holgate ST, Burns GB, Robinson C, Church MK.
    J Immunol; 1984 Oct 15; 133(4):2138-44. PubMed ID: 6206153
    [Abstract] [Full Text] [Related]

  • 20. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli.
    Warner JA, Peters SP, Lichtenstein LM, Hubbard W, Yancey KB, Stevenson HC, Miller PJ, MacGlashan DW.
    J Leukoc Biol; 1989 Jun 15; 45(6):558-71. PubMed ID: 2470847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.